- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05066542
Recreational Basketball to Increase Participation in Diabetes Prevention (DPPHoops)
Leveraging Recreational Basketball to Increase Participation in the National Diabetes Prevention Program (NDPP) Among Adults Aged 18-44 Years at Kaiser Permanente Georgia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The NDPP has successfully helped to reduce the rate of Type 2 Diabetes Mellitus (T2DM) through moderate weight loss and increased physical activity(PA). Kaiser Permanente Georgia (KPGA) members, identified as being at risk to develop type 2 diabetes will be recruited to participate in the intervention trial testing DPP vs. NDPP+ BB study arms. Participants will be randomized into 1 of 2 groups (traditional DPP curriculum or DPP + basketball).
The central objective of this project is to determine the feasibility of adapting the NDPP to include recreational basketball as an exercise component among KPGA population of overweight, pre-diabetic adults ages 18-44 using novel translational science approach and qualitative formative research tools. The secondary objective is to implement the adapted NDPP + BB program among a pre-diabetic KPGA adult members, 18-44 years living in Atlanta and determine post-program efficacy in achieving the desired 5 percent weight loss goal.
The objective is to contribute beneficial information to clinical and operational leaders across KP and beyond, as they consider approaches to improve overall participation rates in the NDPP, particularly for young and middle-aged adult members, leveraging interest in a popular recreational team-based sport such as BB. Longer-term, the goal is to reduce diabetes risk.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30309
- Kaiser Permanente Georgia, Center for Research and Evaluation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 18-44 years
- BMI >= 25 kg/m2
- Previous diagnosis of prediabetes as defined:
- HbA1c 5.7 to 6.4% at baseline
- Not engaged in high exercise levels (self-report of less than 300 minutes of exercise per week)
- Not engaged in other lifestyle intervention program in past 2 years
- Ability to read in English and provide informed consent
- Ability to walk unassisted for 30 minutes
- Ability to jump in place
Exclusion Criteria:
- Diabetes due to underlying conditions
- Type 1 Diabetes
- Type 2 Diabetes
- End Stage Renal Disease (ESRD)
- Myocardial Infarction within the last 12 months
- Cancer treatment
- Congestive Heart Disease
- Not currently pregnant
- Any history of seizures or uncontrolled neurologic or psychiatric condition that may interfere with the intervention plan
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: NDPP Standard of Care SOC
Participants in this arm will participate in the traditional NDPP program delivered virtually by certified NDPP coaches.
During Months 1-4 participants will attend a 60-minute virtually facilitated session of the NDPP curriculum.
During Months 5-8, virtual NDPP curriculum sessions will be held every two weeks.
During Months 9-12, participants will attend a monthly 60-minute NDPP curriculum session.
Participants will submit a weekly weight report during the 12 month participation and will complete the ASA 24 hour food recall every 90 days.
|
DPP: Participants in this arm will participate in the traditional NDPP program delivered virtually by certified NDPP coaches.
During Months 1-4 participants will attend a 60-minute virtually facilitated session of the NDPP curriculum.
During Months 5-8, virtual NDPP curriculum sessions will be held every two weeks.
During Months 9-12, participants will attend a monthly 60-minute NDPP curriculum session.
Participants will submit a weekly weight report during the 12 month participation and will complete the ASA 24 hour food recall every 90 days.
Other Names:
|
Experimental: NDPP + Basketball (BB)
Participants in this arm will participate in the traditional NDPP program delivered virtually by certified NDPP coaches along with virtual fitness sessions and in-person basketball sessions.
During Months 1-4, participants will attend a 60-minute virtually facilitated session of the NDPP curriculum, followed by a 30-minute virtual fitness session.
During that same week, participants will meet in person, for a 90-minute BB session.
During Months 5-8, virtual NDPP curriculum sessions will be held every two weeks and there will no longer be a 30-minute online fitness session succeeding the session.
During this same four-month period, 60-minute, in-person BB sessions will be held weekly.
During Months 9-12, participants will attend a monthly 60-minute NDPP curriculum session and bi-weekly 60-minute in-person BB sessions.
Participants will submit a weekly weight report during the 12 month participation and will complete the ASA 24 hour food recall every 90 days.
|
DPP Hoops: Participants in this arm will participate in the traditional NDPP program delivered virtually by certified NDPP coaches along with virtual fitness sessions and in-person basketball sessions.
During Months 1-4, participants will attend a 60-minute virtually facilitated session of the NDPP curriculum, followed by a 30- minute virtual fitness session.
During that same week, participants will meet in person, for a 90-minute BB session.
During Months 5-8, virtual NDPP curriculum sessions will be held every two weeks and there will no longer be a 30-minute online fitness session succeeding the session.
During this same four-month period, 60-minute, in-person BB sessions will be held weekly.
During Months 9-12, participants will attend a monthly 60-minute NDPP curriculum session and biweekly 60-minute in-person BB sessions.
Participants will submit a weekly weight report during the 12 month participation and will complete the ASA 24 hour food recall every 90 days.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent Weight Loss Efficacy
Time Frame: 12 months
|
Compare percent of program participants achieving 5% or more weight loss between the DPP Standard of care group and the DPP+BB intervention group.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood pressure
Time Frame: 12 months
|
Compare changes between the DPP Standard of care group and the DPP+BB intervention group in mean systolic and diastolic blood pressure (mm Hg)
|
12 months
|
HbA1c
Time Frame: 12 month
|
Compare changes between the DPP Standard of care group and the DPP+BB intervention group in mean HbA1c (percent)
|
12 month
|
Aerobic Fitness
Time Frame: 12 months
|
Compare changes between the DPP Standard of care group and the DPP+BB intervention group in mean aerobic fitness (ml/kg/min)
|
12 months
|
Lipid profile
Time Frame: 12 months
|
Compare changes between the DPP Standard of care group and the DPP+BB intervention group in mean handgrip strenght (pounds)
|
12 months
|
Session attendance
Time Frame: 12 months
|
Compare changes between the DPP Standard of care group and the DPP+BB intervention group in mean number of program sessions attended
|
12 months
|
Physical activity
Time Frame: 12 months
|
Compare changes between the DPP Standard of care group and the DPP+BB intervention group in mean minutes per day of objectively measured sedentary, moderate and vigorous physical activity
|
12 months
|
Waist Circumference
Time Frame: 12 months
|
Compare changes between the DPP Standard of care group and the DPP+BB intervention group in mean waist circumference (cm)
|
12 months
|
% Fat
Time Frame: 12 months
|
Compare changes between the DPP Standard of care group and the DPP+BB intervention group in mean % body fat derived from impedance measurements
|
12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KP1546327
- KPR-SM-2020-01/1 (Other Grant/Funding Number: Kaiser Permanente and National Basketball Association)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PreDiabetes
-
Aga Khan UniversityLinnaeus University; Kenyatta UniversityRecruiting
-
Philip KernNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Chonbuk National University HospitalCompletedPreDiabetes
-
TNOWageningen University and Research; Google LLC.; Jumbo Supermarkten Bv.; Noldus...Completed
-
University of TorontoInternational Nut and Dried Fruit Council (INC); The National Dried Fruit Trade... and other collaboratorsUnknown
-
National Yang Ming UniversityRecruiting
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Clinical Nutrition Research Centre, SingaporeSingapore Institute for Clinical SciencesCompleted
-
Northwestern UniversityAllianceChicago; Erie Family Health CentersCompleted
-
Ohio UniversityTouro University, CaliforniaCompletedPreDiabetes
Clinical Trials on NDPP Standard of Care SOC
-
Rhizen Pharmaceuticals SAIncozen Therapeutics Pvt LtdCompleted
-
TakedaCompletedGaucher DiseaseUnited States
-
South African National Blood ServiceUnknownTherapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19COVID-19 | SARS-CoV-2 Infection | Severe Acute Respiratory Syndrome Coronavirus 2South Africa
-
HeNan Sincere Biotech Co., LtdUnknown
-
SeaStar MedicalWithdrawnCOVID-19 | Continuous Renal Replacement Therapy | Pulmonary Edema
-
Michelle LopezCompleted
-
AKARI TherapeuticsCompletedParoxysmal Nocturnal Hemoglobinuria (PNH)Kazakhstan, Lithuania, Sri Lanka
-
George Washington UniversityMedtronicCompleted
-
AtriCure, Inc.Completed
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingSudden Infant Death | Sudden Unexplained Infant DeathUnited States